[1]
M. Nizamani, “Sarcoidosis after Alemtuzumab therapy: Is Alemtuzumab posing a threat to its patients?”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 41, no. 4, p. e2024036, Dec. 2024, doi: 10.36141/svdld.v41i4.15873.